Clinical Trial

A Study of GZR18 Tablet in Chinese Healthy Subjects

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated August 14, 2024 (before its estimated December 9, 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of the trial is to investigate the the bioavailability, pharmacokinetics, pharmacodynamics, safety and tolerance of single and multiple doses of GZR18 tablet in healthy subjects.
Trial Details
NCT Number NCT06554054
Lead Sponsor Gan and Lee Pharmaceuticals, USA
Conditions Diabetes Mellitus, Type 2
Enrollment 92 participants
Start Date 2024-04-01
Primary Completion 2024-12-09 (estimated)
Study Completion 2024-12-09 (estimated)
Updated on ClinicalTrials.gov 2024-08-14